Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11685561 | 0.73 | PSEN1 (0.38) | NSD2ESR1POLBAPEX1RECQL | |
| SCHEMBL753488 | 0.73 | ALDH1A1 (0.33) | POLBHTTTSHRALDH1A1NT5E | |
| SCHEMBL753489 | 0.72 | ALDH1A1 (0.35) | POLBHTTTSHRALDH1A1NT5E | |
| SCHEMBL11526913 | 0.70 | ALDH1A1 (0.46) | HTTTSHRALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL780499 | 0.67 | ALDH1A1 (0.48) | POLBL3MBTL1HTTALDH1A1LMNA | |
| SCHEMBL6850443 | 0.66 | ALDH1A1 (0.38) | ESR1TDP1L3MBTL1HTTALDH1A1 | |
| SCHEMBL28669397 | 0.65 | ACHE (0.48) | NSD2ESR1POLBAPEX1RECQL | |
| SCHEMBL10112765 | 0.64 | MAPT (0.45) | HTTALDH1A1LMNAHPGDMEN1 | |
| SCHEMBL8958777 | 0.64 | POLB (0.47) | POLBRECQLTDP1L3MBTL1HTT | |
| SCHEMBL11033531 | 0.64 | PTGS2 (0.55) | HTTTSHRALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669342-B1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | KONICA MINOLTA INC (JP) | 2020-03-18 | — | — | EP | disclosed |
| WO-2017032699-A1 | METHOD FOR PRODUCING LOW-BOILING (METH)ACRYLIC ACID ESTERS | BASF SE (DE) | 2017-03-02 | — | — | WO | disclosed |
| US-9416289-B2 | Active-energy-ray-curable inkjet ink composition, active-energy-ray-curable inkjet ink, and inkjet recording method | Konica Minolta, Inc. (JP) | 2016-08-16 | — | — | US | disclosed |
| US-20130307913-A1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | Konica Minolta, Inc. (JP) | 2013-11-21 | — | — | US | disclosed |
| US-8349916-B2 | Actinic energy radiation curable ink-jet ink, ink-jet recording method, and printed matter | KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2228415-B1 | Actinic energy radiation curable ink-jet ink, ink-jet recoring method, and printed matter | KONICA MINOLTA IJ TECHNOLOGIES (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20100255211-A1 | ACTINIC ENERGY RADIATION CURABLE INK-JET INK AND INK-JET IMAGE FORMING METHOD | KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2236568-A1 | Actinic energy radiation curable ink-jet ink and ink-jet image forming method | Konica Minolta IJ Technologies, Inc. (JP) | 2010-10-06 | — | — | EP | disclosed |
| EP-2228415-A1 | Acting energy radiation curable ink-jet ink, ink-jet recoring method, and printed matter | Konica Minolta IJ Technologies, Inc. (JP) | 2010-09-15 | — | — | EP | disclosed |
| WO-2007063031-A2 | STABILIZED POLYMERIZABLE MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-07 | — | — | WO | disclosed |
| US-20060287548-A1 | Radical interceptors as stabilizers of polymerizable compounds | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-21 | — | — | US | disclosed |
| WO-2006122923-A1 | AROMATIC HETEROCYCLES AS STABILIZERS OF POLYMERIZABLE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-23 | — | — | WO | disclosed |
| EP-1670877-A1 | RADICAL INTERCEPTORS AS STABILIZERS OF POLYMERIZABLE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005030907-A1 | RADICAL INTERCEPTORS AS STABILIZERS OF POLYMERIZABLE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-07 | — | — | WO | disclosed |
| EP-1518916-A1 | Scavenger of free radicals as stabilizers of polymerisable compounds | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004104050-A1 | METHOD FOR THE PRODUCTION, TREATMENT AND FURTHER PROCESSING OF POLYMERISABLE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-02 | — | — | WO | disclosed |
| US-20040082737-A1 | Determination of the amount of polymer deposited from (meth) acrylic acid and/or (meth) acrylic esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287548-A1 | Radical interceptors as stabilizers of polymerizable compounds | TTPA, AADAT, TSPO | NSD2 4786/4885ESR1 1467/4885POLB 725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.